Fractal Tun

Fractal Therapeutics is a biotechnology company focused on developing next-generation therapies for metabolic diseases, specifically targeting the root causes of type 2 diabetes and obesity. The company utilizes a systems biology approach and advanced computational modeling to design interventions that aim to provide long-term disease remission rather than just symptom management. Their lead programs focus on optimizing GLP-1 and GIP signaling pathways through novel delivery and molecular mechanisms. Fractal's strategy involves leveraging a deep understanding of metabolic feedback loops to create more durable and effective treatments.